30-Oct-2026 16:35:35
GLAND : APPOINTS AJAY SAHNI AS CEO OF GLAND SINGAPORE SUBSIDIARY
• Ajay Sahni appointed CEO of Gland Pharma International Pte. Ltd. (wholly-owned subsidiary) effective 2nd November, 2026. • He will also be responsible for th…
Latest market headlines for GLAND on Terminal.
30-Oct-2026 16:35:35
• Ajay Sahni appointed CEO of Gland Pharma International Pte. Ltd. (wholly-owned subsidiary) effective 2nd November, 2026. • He will also be responsible for th…
23-Oct-2026 16:21:59
• USFDA concluded an unannounced cGMP inspection at the Dundigal formulation facility between October 12 and October 23, 2026 • Inspection closed with four For…
01-Oct-2026 15:53:24
• Gland Pharma USA Inc. to subscribe to 60% of Novelstar Pharma Inc. equity for USD 21 million. • Novelstar will become a step-down subsidiary of Gland Pharma.…
01-Oct-2026 08:58:03
• Fosun Pharma Industrial Pte. Ltd. disclosed sale of equity shares of Gland Pharma Limited. • Before the sale, the holding was 8,53,93,894 shares (51.76% of t…
30-Sept-2026 11:40:29
• Sale of shares by Mirae Asset Mutual Fund on September 28, 2026. • Holding before sale: 49,30,033 shares (2.99% total voting capital, 2.96% diluted). • Holdi…
13-Sept-2026 16:35:35
• Gland Pharma USA Inc. (“Gland US”) is a wholly-owned step-down subsidiary. • Share Capital of Gland US: USD 500,000; Turnover: Nil for FY ending March 31, 20…